Clinical Trial Update: Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid in Colistin-Induced Nephrotoxicity [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluated the efficacy and safety of N-acetylcysteine versus alpha-lipoic acid in colistin-induced nephrotoxicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Nephrotoxicity | Phase 2, Phase 3 | Status: COMPLETED